Saint-Clément-de-la-Place, France

Josy Froger

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josy Froger. Retrieved from https://idiyas.com/inventor/josy-froger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Josy Froger: Innovator in Hepcidin Research

Introduction

Josy Froger is a notable inventor based in Saint Clement de la Place, France. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies specific for human hepcidin. His work has implications for diagnosing and treating diseases associated with this important protein.

Latest Patents

Josy Froger holds a patent for "Antibodies specific for human hepcidin." This invention relates to antigen-binding proteins that have specificity for hepcidin, which can be utilized in the treatment and diagnosis of various diseases linked to hepcidin levels.

Career Highlights

Throughout his career, Josy Froger has worked with prestigious institutions such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of hepcidin and its role in human health.

Collaborations

Some of his notable coworkers include Sophie Vaulont and Hugues Gascan. Their collaborative efforts have contributed to the advancements in the field of hepcidin research.

Conclusion

Josy Froger's innovative work in developing specific antibodies for hepcidin showcases his commitment to advancing medical science. His contributions are vital for future research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…